Clinical Trial Update: AST-120 Used to Treat Mild Hepatic Encephalopathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating AST-120 for hepatic encephalopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy

Drugs mentioned

• AST-120 (AST-120)

Snippet

Sponsor: Ocera Therapeutics | Conditions: Mild Hepatic Encephalopathy | Phase 2 | Status: COMPLETED